Soft Tissue Rheumatism. Insulin Resistance Soft tissue rheumatism. Insulin resistance.. Metformin.
Conditions
Interventions
Patients will recieve Metformin 1500 mg orally dialy in two devided doses for 12 months peroid.,Patients will recieve ultrasound therapy, physiotherapy in the form of stretching excercises, cold fomen
Metformin,Ultrasound, physiotherapy
Sponsors
Alazhar University Hospital at New Damietta
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1.Patient diagnosed as having soft tissue rheumatism (Plantar fasciitis, rotator cuff tendinitis), 2.Age ranges from eighteen (18) to sixty (60) years to avoid complaints related to congenital causes as uneven legs, Multidirectional shoulder instability or aging, 3.Body mass index > 25
Exclusion criteria
Exclusion criteria: 1.History of trauma, 2.Overwork, Unaccustomed activities, 3.Systemic rheumatic diseases, severe co-morbid diseases, Diabetes mellitus, 4.Drugs that can affect insulin resistance or musculoskeletal system, 5.Poor postures and poor footwear.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement soft tissue rheumatism At 12 months after end of the intervention VAS score | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of Homa-IR At 12 months after end of the intervention Homa-IR | — |
Countries
Egypt
Contacts
Public ContactTarek Emran
AlAzhar University
Outcome results
None listed